Why is SLS Down Today?
About SELLAS Life Sciences Group, Inc. Common Stock
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tu...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.4%
Market Comparison
Quick Trade Ideas
Options strategies to consider for SLS's -8% move
No Options Available
SLS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get SLS Alerts
We'll notify you when SLS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
SLS has moved more than 3.0% down on 68 occasions in the past year.
Frequently Asked Questions
Why is SLS stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.4% on average.
Is SLS stock a buy or sell right now?
Based on current analysis, SLS shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the SLS stock price target?
SLS is currently trading at $11.37. Based on today's momentum, the expected short-term range is $11.03 - $11.60. See long-term price prediction →
Will SLS stock continue falling?
Our analysis shows a 45% probability that SLS's move continues in the next 1-3 days. Key level to watch: $10.80 (support).
Is SLS stock oversold or overbought?
SLS's RSI (Relative Strength Index) is currently at 43.8. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for SLS stock?
SLS's 10-day momentum indicator is at -0.2. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is SLS outperforming or underperforming the market?
SLS (-7.64%) is currently significantly underperforming the market (-7.8% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for SLS?
SLS's MACD (-0.36) is currently below the signal line (-0.34), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 18.3) is weak.
Is SLS in an uptrend or downtrend?
Based on moving average analysis, SLS is in a bearish trend. The price ($11.37) is trading below both the 20-day SMA ($12.17) and 50-day SMA ($12.32). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis